Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis

FRIDAY, Nov. 1, 2019 -- For patients with cystic fibrosis with Phe508del-minimal function genotypes, elexacaftor-tezacaftor-ivacaftor, which was recently approved by the U.S. Food and Drug Administration, is efficacious, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news